Expression of EXT2 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

EXT2 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 30.43

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

40.0

Number of samples

141

Samples

Sample	Description	TPM
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	78.5
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	71.7
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	70.9
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	69.8
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	69.1
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	67.0
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	63.9
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	61.6
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	61.3
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	60.8
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	60.3
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	59.1
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	58.6
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	57.8
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	57.3
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	57.2
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	56.8
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	54.2
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	53.2
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	52.9
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	52.1
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	51.2
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	51.2
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	51.1
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	51.0
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	50.4
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	50.1
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	49.6
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	49.5
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	48.9
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	48.9
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	48.1
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	47.8
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	47.7
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	47.6
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	47.0
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	46.9
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	46.9
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	46.7
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	46.4
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	46.0
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	45.7
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	45.7
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	45.5
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	45.5
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	45.2
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	45.0
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	44.9
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	44.8
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	44.6
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	44.3
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	44.2
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	44.0
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	43.7
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	43.4
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	42.9
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	42.9
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	42.8
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	42.8
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	42.8
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	42.6
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	42.4
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	42.0
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	41.3
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	41.2
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	41.2
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	41.0
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	40.9
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	40.7
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	40.6
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	40.4
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	40.1
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	39.7
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	39.5
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	39.4
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	39.0
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	39.0
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	38.8
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	38.4
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	38.3
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	37.9
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	37.3
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	37.3
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	36.1
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	36.1
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	35.9
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	35.2
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	35.2
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	35.2
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	35.1
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	34.8
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	34.1
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	34.1
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	33.9
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	33.4
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	32.9
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	32.6
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	32.5
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	32.3
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	32.2
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	32.0
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	31.8
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	31.7
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	31.3
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	31.0
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	31.0
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	30.6
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	30.5
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	30.3
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	29.7
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	29.0
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	29.0
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	28.9
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	28.8
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	28.5
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	28.4
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	28.2
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	28.1
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	28.0
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	28.0
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	26.6
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	26.4
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	26.2
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	25.5
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	25.3
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	24.6
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	24.4
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	24.4
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	23.9
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	22.8
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	21.8
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	21.6
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	21.5
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	20.5
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	20.0
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	19.6
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	18.9
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	17.4
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	16.3
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	13.4
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	8.6
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

EXT2 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 19.83

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

18.3

Number of samples

Samples

Sample	Description	TPM
AK153	N, NA, stage:NA, dead, 240 days	30.0
AK185	N, NA, stage:NA, alive, 330 days	29.5
AK003	N, NA, stage:NA, dead, 600 days	25.2
AK123	N, NA, stage:NA, dead, 180 days	24.9
AK076	N, NA, stage:NA, alive, 660 days	24.9
AK139	N, NA, stage:NA, dead, 270 days	24.6
AK098	N, NA, stage:NA, dead, 660 days	24.0
AK030	N, NA, stage:NA, dead, 120 days	23.1
AK088	N, NA, stage:NA, dead, 360 days	22.9
AK216	N, NA, stage:NA, dead, 360 days	22.3
AK227	N, NA, stage:NA, alive, 300 days	22.0
AK089	N, NA, stage:NA, dead, 330 days	21.7
AK188	N, NA, stage:NA, alive, 420 days	21.7
AK051	N, NA, stage:NA, dead, 360 days	21.4
AK236	N, NA, stage:NA, dead, 360 days	21.3
AK205	N, NA, stage:NA, dead, 120 days	20.9
AK072	N, NA, stage:NA, dead, 150 days	20.3
AK081	N, NA, stage:NA, dead, 180 days	20.2
AK053	N, NA, stage:NA, dead, 300 days	19.9
AK100	N, NA, stage:NA, alive, 960 days	19.8
AK195	N, NA, stage:NA, dead, 390 days	19.4
AK133	N, NA, stage:NA, dead, 360 days	19.2
AK041	N, NA, stage:NA, alive, 810 days	19.2
AK199	N, NA, stage:NA, alive, 1860 days	19.0
AK035	N, NA, stage:NA, dead, 210 days	18.6
AK079	N, NA, stage:NA, dead, 210 days	18.6
AK043	N, NA, stage:NA, alive, 660 days	18.4
AK071	N, NA, stage:NA, dead, 540 days	18.4
AK226	N, NA, stage:NA, dead, 360 days	18.2
AK074	N, NA, stage:NA, alive, 300 days	18.1
AK099	N, NA, stage:NA, dead, 420 days	18.0
AK218	N, NA, stage:NA, dead, 180 days	17.8
AK103	N, NA, stage:NA, alive, 1320 days	17.8
AK068	N, NA, stage:NA, alive, 360 days	17.1
AK213	N, NA, stage:NA, alive, 2010 days	17.0
AK085	N, NA, stage:NA, alive, 660 days	16.6
AK124	N, NA, stage:NA, alive, 1920 days	16.6
AK117	N, NA, stage:NA, dead, 210 days	16.5
AK055	N, NA, stage:NA, dead, 240 days	16.1
AK149	N, NA, stage:NA, dead, 420 days	16.0
AK102	N, NA, stage:NA, alive, 1740 days	16.0
AK091	N, NA, stage:NA, dead, 210 days	15.9
AK049	N, NA, stage:NA, dead, 180 days	15.7
AK165	N, NA, stage:NA, alive, 360 days	15.2
AK005	N, NA, stage:NA, dead, 240 days	15.1
AK158	N, NA, stage:NA, dead, 360 days	15.1
AK156	N, NA, stage:NA, dead, 330 days	14.7
AK006	N, NA, stage:NA, dead, 360 days	14.4
AK173	N, NA, stage:NA, dead, 180 days	14.4
AK183	N, NA, stage:NA, alive, 360 days	13.9
AK231	N, NA, stage:NA, dead, 240 days	13.8
AK178	N, NA, stage:NA, dead, 240 days	13.4
AK134	N, NA, stage:NA, dead, 360 days	13.0
AK142	N, NA, stage:NA, alive, 90 days	12.3
AK167	N, NA, stage:NA, dead, 180 days	12.3
AK015	N, NA, stage:NA, alive, 720 days	12.1
AK066	N, NA, stage:NA, alive, 960 days	10.6
AK002	N, NA, stage:NA, dead, 570 days	9.4
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0087730003	Tumor	0.9
CPT0217710008	Tumor	0.8
CPT0162100003	Tumor	0.7
CPT0217000004	Tumor	0.7
CPT0206670004	Tumor	0.6
CPT0216920008	Tumor	0.6
CPT0218330004	Tumor	0.5
CPT0218690004	Tumor	0.5
CPT0093510003	Tumor	0.5
CPT0087570003	Tumor	0.5
CPT0127480003	Tumor	0.5
CPT0089150003	Tumor	0.5
CPT0093550003	Tumor	0.5
CPT0123530003	Tumor	0.4
CPT0182500003	Tumor	0.4
CPT0064650003	Tumor	0.4
CPT0205570003	Tumor	0.4
CPT0224390004	Tumor	0.4
CPT0207090003	Tumor	0.4
CPT0167750004	Tumor	0.4
CPT0071100003	Tumor	0.4
CPT0079790003	Tumor	0.4
CPT0218830004	Tumor	0.4
CPT0189650004	Tumor	0.4
CPT0206110003	Tumor	0.3
CPT0189570004	Tumor	0.3
CPT0093360003	Tumor	0.3
CPT0161730003	Tumor	0.3
CPT0092440003	Tumor	0.3
CPT0168480003	Tumor	0.3
CPT0206450003	Tumor	0.3
CPT0206780003	Tumor	0.3
CPT0167530003	Tumor	0.3
CPT0182580003	Tumor	0.3
CPT0206560003	Tumor	0.3
CPT0190360004	Tumor	0.3
CPT0125220003	Tumor	0.3
CPT0104220003	Tumor	0.3
CPT0162020003	Tumor	0.3
CPT0168830003	Tumor	0.3
CPT0168080003	Tumor	0.2
CPT0167860004	Tumor	0.2
CPT0087950003	Tumor	0.2
CPT0218960004	Tumor	0.2
CPT0205450004	Tumor	0.2
CPT0127420003	Tumor	0.2
CPT0064890003	Tumor	0.2
CPT0167970003	Tumor	0.2
CPT0208980003	Tumor	0.2
CPT0002410011	Tumor	0.2
CPT0078580003	Tumor	0.1
CPT0093590003	Tumor	0.1
CPT0218770003	Tumor	0.1
CPT0196850003	Tumor	0.1
CPT0224540004	Tumor	0.1
CPT0205780003	Tumor	0.1
CPT0167640003	Tumor	0.1
CPT0189850004	Tumor	0.1
CPT0189750004	Tumor	0.1
CPT0168590003	Tumor	0.1
CPT0219080004	Tumor	0.1
CPT0205670004	Tumor	0.1
CPT0186100003	Tumor	0.1
CPT0175060003	Tumor	0.1
CPT0205890003	Tumor	0.1
CPT0189460003	Tumor	0.1
CPT0206230003	Tumor	0.1
CPT0207030003	Tumor	0.1
CPT0206000004	Tumor	0.1
CPT0206880003	Tumor	0.1
CPT0217060003	Tumor	0.1
CPT0224600003	Tumor	0.0
CPT0168380003	Tumor	0.0
CPT0225760003	Tumor	0.0
CPT0217430008	Tumor	0.0
CPT0104330003	Tumor	0.0
CPT0162140003	Tumor	0.0
CPT0199770003	Tumor	-0.1
CPT0168270003	Tumor	-0.1
CPT0217190003	Tumor	-0.1
CPT0225730003	Tumor	-0.1
CPT0228220003	Tumor	-0.1
CPT0217100003	Tumor	-0.1
CPT0218670003	Tumor	-0.1
CPT0168720003	Tumor	-0.1
CPT0087680003	Tumor	-0.1
CPT0204350003	Normal	-0.1
CPT0093450003	Tumor	-0.2
CPT0206330003	Tumor	-0.2
CPT0171580008	Tumor	-0.2
CPT0224330003	Tumor	-0.2
CPT0201710003	Tumor	-0.2
CPT0204410003	Normal	-0.2
CPT0221180003	Tumor	-0.2
CPT0189250003	Tumor	-0.2
CPT0125570003	Tumor	-0.2
CPT0204360003	Normal	-0.2
CPT0217880003	Tumor	-0.2
CPT0204380003	Normal	-0.2
CPT0190240004	Tumor	-0.3
CPT0204400003	Normal	-0.3
CPT0218890004	Tumor	-0.3
CPT0204370003	Normal	-0.3
CPT0182550003	Tumor	-0.3
CPT0209440003	Tumor	-0.3
CPT0204330003	Normal	-0.4
CPT0125510003	Tumor	-0.4
CPT0204390003	Normal	-0.4
CPT0204420003	Normal	-0.4
CPT0204340003	Normal	-0.6
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis